Ellen Bubrick News Today : Breaking News, Live Updates & Top Stories | Vimarsana

uniQure (QURE) Highlights Therapeutic Potential of AMT-260 in Refractory Temporal Lobe Epilepsy (rTLE) at Virtual Research & Development Event

uniQure (QURE) Highlights Therapeutic Potential of AMT-260 in Refractory Temporal Lobe Epilepsy (rTLE) at Virtual Research & Development Event
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRicardo dolmetschEllen bubrickPierre calozAdvances in manufacturing platform technologyNeurology at harvard medical schoolEpilepsy surgery program at brighamWall streetHarvard medical schoolEpilepsy surgery programTemporal lobe epilepsyManufacturing platform technologyTemporal lobe epilepsytemporal

uniQure Inc : uniQure to Host Virtual Research & Development Event on Tuesday, November 29, 2022

~ Event to be Webcast Live on uniQure's Corporate Website at 8:30 a.m. EST ~ LEXINGTON, Ma. and AMSTERDAM, Nov. 17, 2022(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies

United statesNoord hollandChiara russoPierre calozEllen bubrickMariae cantorTom maloneQure researchVirtual research development event onHarvard medical schoolEpilepsy surgery program at brighamWebcast liveCorporate websiteVirtual researchDevelopment eventEpilepsy surgery program

uniQure to Host Virtual Research & Development Event on

~ Event to be Webcast Live on uniQure’s Corporate Website at 8:30 a.m. EST ~ LEXINGTON, Ma. and AMSTERDAM, Nov. 17, 2022 (GLOBE NEWSWIRE) uniQure.

United statesNoord hollandChiara russoPierre calozEllen bubrickMariae cantorTom maloneQure researchVirtual research development event onHarvard medical schoolEpilepsy surgery program at brighamWebcast liveCorporate websiteVirtual researchDevelopment eventEpilepsy surgery program